STOCK TITAN

Agiliti, Inc. - AGTI STOCK NEWS

Welcome to our dedicated page for Agiliti news (Ticker: AGTI), a resource for investors and traders seeking the latest updates and insights on Agiliti stock.

Agiliti, Inc. (NYSE: AGTI) is a leading healthcare technology management and service solutions provider in the United States, serving over 10,000 national, regional, and local acute care and alternate site providers. With a team of 3,000 dedicated equipment management experts, Agiliti is committed to optimizing clinical outcomes and improving economic efficiency for its customers. The company’s comprehensive suite of services includes medical equipment management, clinical engineering services, and on-site managed services, which help healthcare providers reduce costs, increase operational efficiency, and deliver optimal patient outcomes.

In recent financial highlights, Agiliti reported a revenue growth of 6.2% for Q2 2023, reaching $291 million. Despite a net loss of $4 million, the company maintained a positive outlook on business visibility and predictability, forecasting annual revenues between $1.16 billion and $1.19 billion. Agiliti has adjusted its EBITDA guidance to $260-$270 million for 2023, reflecting the impact of contract onboarding and business mix changes. The company’s strategic initiatives include a $50 million share repurchase program, indicating confidence in its long-term strategy.

Agiliti’s leadership also saw changes with the return of Tom Leonard as CEO in October 2023, following the departure of Tom Boehning. Under Leonard’s leadership, Agiliti aims to continue its growth trajectory and strengthen its position in the healthcare technology management sector. Key announcements include the company’s agreement to be acquired by Thomas H. Lee Partners, L.P. for $10.00 per share, valuing Agiliti at approximately $2.5 billion, a transaction expected to close in the first half of 2024. This move is poised to further enhance Agiliti’s operational capabilities and market reach.

Agiliti’s annual and quarterly financial results reflect consistent performance, with notable earnings and revenue growth despite industry challenges. The company’s commitment to innovation and client-centric service delivery underscores its role as an essential partner in the U.S. healthcare system.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-27.95%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.79%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.75%
Tags
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.86%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.23%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.18%
Tags
conferences
Rhea-AI Summary

Agiliti Inc. (NYSE: AGTI) will release its first quarter 2023 financial results on May 9, 2023, after market close, followed by a conference call at 5 p.m. Eastern Time. The call can be accessed by dialing 1-877-407-0792, with international callers using 1-201-689-8263. A replay will be available two hours post-call until May 16, 2023. Agiliti, a key service provider in the U.S. healthcare sector, has over 10,000 clients and specializes in medical equipment management, focusing on cost reduction, operational efficiency, and improved patient outcomes. The company has a rich history of more than 80 years in delivering innovative solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.31%
Tags
-
Rhea-AI Summary

Agiliti Inc. (NYSE: AGTI) will participate in the KeyBanc Life Sciences & MedTech Investor Forum on March 22, 2023. Management will conduct virtual 1x1 investor meetings and host a fireside chat at 11:15 a.m. Eastern Time on the same day. Interested parties can access the webcast through the Investor Relations section of the company's website. Agiliti is a key service provider to the U.S. healthcare sector, offering solutions that enhance operational efficiency and support patient outcomes. With over eight decades of experience, Agiliti serves more than 9,000 healthcare providers nationwide.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.21%
Tags
conferences
-
Rhea-AI Summary

Agiliti Inc. (NYSE: AGTI) reported its fourth quarter and full-year financial results for 2022, revealing a 3% decrease in Q4 revenue to $282 million compared to the previous year. Net income for Q4 fell to $3.4 million, down from $10 million, with diluted earnings per share of $0.02. For the full year, revenue increased 8% to $1.12 billion, and net income rose to $30.2 million. The company provided optimistic guidance for 2023, projecting revenue between $1.16 billion and $1.19 billion and adjusted EBITDA of $295-$305 million. The management highlighted significant business milestones despite pandemic challenges.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.13%
Tags
Rhea-AI Summary

Agiliti, Inc. (NYSE: AGTI) is set to announce its fourth quarter and full year 2022 financial results on March 7, 2023, after market close. A conference call will take place at 5 p.m. Eastern Time on the same day, accessible via phone or online through the company's Investor Relations website. Agiliti, a key service provider in the U.S. healthcare industry, serves over 9,000 healthcare providers, offering solutions to enhance operational efficiency and patient outcomes. The company has a long-standing history of over 80 years in medical equipment management.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.8%
Tags

FAQ

What is the current stock price of Agiliti (AGTI)?

The current stock price of Agiliti (AGTI) is $10.05 as of May 6, 2024.

What is the market cap of Agiliti (AGTI)?

The market cap of Agiliti (AGTI) is approximately 1.4B.

What services does Agiliti, Inc. provide?

Agiliti, Inc. provides medical equipment management, clinical engineering services, and on-site managed services to healthcare providers across the United States.

What is Agiliti's recent financial performance?

For Q2 2023, Agiliti reported a revenue growth of 6.2% to $291 million, though it experienced a net loss of $4 million. The company maintains a positive annual revenue forecast of $1.16 - $1.19 billion.

Who is the CEO of Agiliti, Inc.?

As of October 2023, Tom Leonard serves as the CEO of Agiliti, Inc., returning to the role after leading the company from 2015 to 2023.

What are Agiliti's future financial projections?

Agiliti projects an adjusted EBITDA of $260-$270 million and adjusted earnings per share of $0.54-$0.59 for the year 2023.

Has Agiliti announced any significant corporate actions?

Yes, Agiliti announced a $50 million share repurchase program and its acquisition by Thomas H. Lee Partners, L.P. for $10.00 per share, estimated to close in the first half of 2024.

What is the purpose of Agiliti's share repurchase program?

The share repurchase program, valued at $50 million, reflects Agiliti's confidence in its long-term strategy and aims to deliver value to its shareholders.

Where can I find Agiliti's financial reports and conference call details?

Agiliti's financial reports and conference call details can be accessed on the Investor Relations section of their website at https://investors.agilitihealth.com.

What challenges is Agiliti facing in the current market?

Agiliti faces challenges such as market volatility, substantial debt obligations, and the need for significant cash to operate and expand its business as planned.

How does Agiliti support the healthcare industry?

Agiliti supports the healthcare industry by providing essential medical equipment management and service solutions, enhancing clinical efficiencies, cost savings, and patient outcomes.

What is the status of Agiliti's acquisition by Thomas H. Lee Partners?

The acquisition by Thomas H. Lee Partners is expected to close in the first half of 2024, after which Agiliti will become a private company and delist from the NYSE.

Agiliti, Inc.

NYSE:AGTI

AGTI Rankings

AGTI Stock Data

1.37B
135.96M
1.7%
99.76%
0.8%
Health Information Services
Services-miscellaneous Equipment Rental & Leasing
Link
United States of America
EDEN PRAIRIE